Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Soad Bekheit, Staten Island University Hospital
ClinicalTrials.gov Identifier:
NCT01590979
First received: April 27, 2012
Last updated: April 16, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)